Bcl-2 phosphorylation in a human breast carcinoma xenograft: a common event in response to effective DNA-damaging drugs

This publication has 18 references indexed in Scilit:

• Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts.
  British Journal of Cancer, 1998
• Role of apoptotic response in cellular resistance to cytotoxic agents
  Pharmacology & Therapeutics, 1997
• Efficacy of lonidamine combined with different DNA-damaging agents in the treatment of the MX-1 tumor xenograft
  Cancer Chemotherapy and Pharmacology, 1996
• Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance
  Current Opinion in Oncology, 1995
• Inactivation of Bcl-2 by phosphorylation.
  Proceedings of the National Academy of Sciences, 1995
• Bcl-2 and the regulation of programmed cell death
  The Journal of cell biology, 1994
• High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy
  Blood, 1993
• Overexpressed full-length human BCL2 extends the survival of baculovirus-infected Sf9 insect cells.
  Proceedings of the National Academy of Sciences, 1992
• BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense.
  Proceedings of the National Academy of Sciences, 1990
• Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells
  Nature, 1988